In this endocrinology month in review for March 2024, we recap the most popular FDA news and pipeline updates as well as recognizing the 2-year anniversary of Diabetes Dialogue.
A community of people with type 1 diabetes got a self-built device approved. What can they offer that big companies can’t? A community of people with type 1 diabetes got a self-built device approved. What can they offer that big companies can’t?
The Insulin Pumps Market revenues were estimated at US$ 5.5 Bn in 2022 and are anticipated to grow at a CAGR of 10.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 14.8 Bn. The demand for tethered pumps is projected to garner.